InflaRx CEO Dr. Niels Riedmann joins Rx for Biotech to discuss how the company is pioneering complement-directed therapies to control severe inflammation and autoimmune disease. We break down the science behind INF904, and why C5a is such a powerful immune driver, and how precision immunology is shaping the next wave of treatment innovation.

A New Hope for Skin Cancer: The Story Behind a Promising Immunotherapy

"Rx for Biotech" is a healthcare education podcast dedicated to helping patients, caregivers, and healthcare professionals understand the rapidly evolving world of advanced therapies - and how patients can access them. From cell therapies and gene therapies to radiopharmaceuticals, immunotherapies, and next-generation treatments for cancer and autoimmune disease, this channel bridges the gap between breakthrough science and real-world patient care.  

Hosted by Chris Leidli, founder of Genoplex and longtime host of the Rx for Biotech podcast, each episode features conversations with:
•	Biotech and pharmaceutical CEOs
•	Physician leaders and researchers
•	AI and tech leaders building tools to improve healthcare access
•	Innovators building the next generation of personalized therapies

About Therapy4me.ai
Therapy4me.ai is a consumer education and care-navigation platform designed to help patients find and connect with specialists at treatment centers offering personalized medicines and advanced therapies. 

Learn more: https://www.therapy4me.ai

To learn more about Genoplex, please visit https://www.genoplex.ai